Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-28 @ 12:30 AM
Study NCT ID:
NCT01578668
Status:
COMPLETED
Last Update Posted:
2015-01-26
First Post:
2012-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Sponsor:
Guangzhou Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01
Start Date Type:
None
Primary Completion Date:
2015-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-11
First Submit QC Date:
None
Study First Post Date:
2012-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-01-23
Last Update Post Date:
2015-01-26
Last Update Post Date Type:
ESTIMATED